Exagen Inc.
- XGN
- NASDAQ
- Medical - Diagnostics & Research
- Rheumatology Diagnostics
- Autoimmune Testing (AVISE)
$7.47
Today −3.24%Quote Oct 19, 2026, 06:39 PM UTC
−1.91%over the last month
Max drawdown −11.7%From 1-month high −11.7%3 months +65.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Exagen
Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the United States.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
216
Founded
2002
Market value
$181.0M
Quote Oct 19
Floor
$7.16
4.1% below price
Resistance
$7.53
0.8% above price
Price vs analyst targets
10 analysts
Lowest target
$8.00Highest target
$11.00
$8.00Highest target
$11.00
- Price $7.47
- Average target $9.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 20% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about XGNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free